Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer ceil subpopulations

Clinical Cancer Research

Volumn 15, Issue 1, 2009, Pages 70-80

  Katz, Ehood ^b   Skorecki, Karl ^a,b   Tzukerman, Maty ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARBOPLATIN; DOXORUBICIN; GELATINASE A; GELATINASE B; GEMCITABINE; MUCIN 1; PACLITAXEL; TOPOTECAN;

ABDOMINAL HYSTERECTOMY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES FLUID; CANCER CELL; CANCER GROWTH; CANCER MODEL; CARCINOGENICITY; CELL ACTIVITY; CELL SUBPOPULATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; EXPERIMENTAL MOUSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MICROENVIRONMENT; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALPINGOOOPHORECTOMY; TUMOR XENOGRAFT;

ADENOCARCINOMA, CLEAR CELL; ANIMALS; ASCITES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 58849134940     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1233     Document Type: Article

References (42)

1. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003;3:422-33.
2. Folkman J. A novel anti-vascular therapy for cancer. Cancer Biol Ther 2004;3:338-9.
3. Coussens LM.Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
4. DeVisser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005;7:411 -23.
5. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, TIsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002-11.
6. Kuperwasser C, ChavarriaT, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 2004;101:4966-71.
7. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006;5: 1597-601.
8. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
9. Sung SY, Hsieh CL,Wu D, Chung LW, Johnstone PA. Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr Probl Cancer 2007;31:36-100.
10. Hanahan D,Weinberg RA.The hallmarks of cancer. Cell 2000;100:57-70.
11. GuoW, LaskyJL III, Wu H. Cancer stem cells. Pediatr Res 2006;59:59-64R.
12. Bapat SA. Evolution of cancer stem cells. Semin Cancer Biol 2007;17:204-13.
13. Wicha MS. Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 2006;12:5606-7.
14. Reya T,Morrison SJ, Clarke MF.Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
15. Al-Hajj M. Cancer stem cells and oncology therapeutics. Curr Opin Oncol 2007;19:61 -4.
16. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumor initiating cells. Nature 2004; 432:396-401.
17. Buick RN, Pollak MN. Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res 1984;44:4909-18.
18. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-7.
19. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-8.
20. Rangarajan A, Weinberg RA. Comparative biology of mouse versus human cells: modeling human cancer in mice. Nat Rev Cancer 2003;3:952-9.
21. Herzig M, Christofori G. Recent advances in cancer research: mouse models of tumorigenesis. Biochim Biophys Acta 2002;1602:97-113.
22. Lensch MW, InceTA. The terminology of teratocarcinomas and teratomas. Nat Biotechnol 2007;25:1211.
23. Tzukerman M, RosenbergT RavelY, Reiter I, Coleman R, Skorecki K. An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2003;100:13507-12.
24. Tzukerman M, RosenbergT, Reiter I, et al. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res 2006;66:3792-801.
25. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 1990;43:213-9.
26. Auersperg N, Maines-Bandiera SL, Dyck HG, Kruk PA. Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab Invest 1994;71:510-8.
27. Schwartz DR, Wu R, Kardia SL, et al. Novel candidate targets of βcatenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 2003;63:2913-22.
28. Nomura H, Mai M. Enhanced expression of CA19-9 in mucinous gastric carcinoma. Am J Gastroenterol 1997;92:2331-2.
29. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996;7:565-77.
30. Bast RC Jr. Urban N, ShridharV, et al. Early detection of ovarian cancer: promise and reality. Cancer Treat Res 2002;107:61-97.
31. 1 phase in uterine cervical adenocarcinoma cell line. Gynecol Oncol 1998;71:442-9.
32. Wu C, Cipollone J, Maines-Bandiera S, et al. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression. Differentiation 2008:76: 193-205.
33. Elloul S, Silins I, Tropé CG, Benshushan A, Davidson B, Reich R. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch 2006; 449:520-8.
34. Maines-Bandiera SL, Kruk PA, Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol 1992;167:729-35.
35. Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005:5:355-66.
36. Davidson B, Goldberg I, Gotlieb WH, et al. The prognostic value of metalloproteinases and angiogenic fac tors in ovarian carcinoma. Mol Cell Endocrinol 2002. 187:39-45.
37. Kenny HA, Kaur S, Coussens LM, Lengyel E The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008;118:1367 - 79.
38. Czernobilsky B, Silverman BB, Mikuta JJ Endometrioid carcinoma of the ovary. A clinicopathologic study of 75 cases. Cancer 1970:26:1141 - 52.
39. Bapat SA, Mali AM, Koppikar CB, Kurrey NK Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer Cancer Res 2005;65:3025-9.
40. Kelly PN. Dakic A, Adams JM, Nutt SL. Strasser A Tumor growth need not be driven by rare cancer stem cells. Science 2007;317:337.
41. Bendall SC, Stewart MH, Menendez P. et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007: 448:1015-21.
42. Zhang J, Li L. Stem cell niche: microenvironment and beyond. J Biol Chem 2008:283 9499 - 503.